JANE STREET GROUP, LLC - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 150 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$197,000
-53.4%
13,041
-76.9%
0.00%
Q2 2022$423,000
-3.0%
56,463
-9.0%
0.00%
Q4 2021$436,000
+54.6%
62,058
+150.7%
0.00%
Q3 2021$282,000
+13.3%
24,754
+78.2%
0.00%
Q1 2021$249,000
-64.7%
13,893
-73.4%
0.00%
Q4 2020$706,000
+380.3%
52,255
+318.0%
0.00%
Q3 2020$147,000
-65.8%
12,500
-57.1%
0.00%
Q2 2020$430,000
-77.7%
29,115
-63.5%
0.00%
-100.0%
Q4 2019$1,929,000
+105.2%
79,796
+63.2%
0.00%
+50.0%
Q3 2019$940,000
+244.3%
48,900
+1003.1%
0.00%
+100.0%
Q3 2018$273,000
-84.9%
4,433
-83.4%
0.00%
-75.0%
Q2 2018$1,804,000
-2.2%
26,700
-13.5%
0.00%
-33.3%
Q4 2017$1,844,000
+59.1%
30,866
+29.5%
0.01%
+50.0%
Q3 2017$1,159,000
+172.1%
23,829
+194.2%
0.00%
+300.0%
Q2 2017$426,000
+73.9%
8,100
+50.0%
0.00%0.0%
Q1 2017$245,000
-95.4%
5,400
-96.2%
0.00%
-96.2%
Q3 2016$5,382,000
+939.0%
142,618
+570.0%
0.03%
+766.7%
Q4 2015$518,000
+18.8%
21,286
-13.5%
0.00%
+50.0%
Q3 2015$436,000
+19.8%
24,602
+112.0%
0.00%
-33.3%
Q1 2015$364,000
+57.6%
11,606
+24.3%
0.00%0.0%
Q2 2014$231,0009,3380.00%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders